Renaissance Technologies ABIOMED INC ownership

ABIOMED INC's ticker is ABMD and the CUSIP is 003654100. A total of 496 filers reported holding ABIOMED INC in Q3 2022. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.

Renaissance Technologies ownership history of ABIOMED INC
ValueSharesWeighting
Q3 2022$310,956
-13.1%
1,265,800
-12.5%
0.44%
+3.8%
Q2 2022$358,029
-23.6%
1,446,523
+2.3%
0.42%
-22.9%
Q1 2022$468,440
-10.1%
1,414,200
-2.6%
0.55%
-15.1%
Q4 2021$521,263
+2.4%
1,451,300
-7.2%
0.65%
-1.4%
Q3 2021$509,023
-2.9%
1,563,723
-6.9%
0.66%
+0.5%
Q2 2021$524,009
-7.6%
1,678,923
-5.7%
0.65%
-7.4%
Q1 2021$567,379
-12.2%
1,780,123
-10.7%
0.71%
+0.6%
Q4 2020$646,390
+3.4%
1,993,800
-11.7%
0.70%
+12.5%
Q3 2020$625,358
+15.1%
2,257,123
+0.3%
0.62%
+33.0%
Q2 2020$543,539
+82.8%
2,250,122
+9.9%
0.47%
+62.3%
Q1 2020$297,288
-25.0%
2,048,000
-11.8%
0.29%
-5.2%
Q4 2019$396,284
+4.3%
2,323,023
+8.8%
0.30%
-5.3%
Q3 2019$379,924
-40.0%
2,135,723
-12.2%
0.32%
-42.3%
Q2 2019$633,440
+7.6%
2,431,723
+18.0%
0.56%
+4.3%
Q1 2019$588,579
-3.2%
2,060,923
+10.2%
0.54%
-19.5%
Q4 2018$607,735
-21.4%
1,869,723
+8.8%
0.66%
-16.4%
Q3 2018$773,131
-20.2%
1,719,023
-36.4%
0.80%
+50.3%
Q2 2018$969,139
+189.7%
2,701,046
+135.0%
0.53%
+44.5%
Q1 2018$334,529
+64.9%
1,149,623
+6.2%
0.37%
+63.4%
Q4 2017$202,913
+10.6%
1,082,723
-0.5%
0.22%
+3.7%
Q3 2017$183,508
+43.4%
1,088,424
+21.9%
0.22%
+32.5%
Q2 2017$127,999
+52.9%
893,223
+33.6%
0.16%
+39.3%
Q1 2017$83,721
+41.8%
668,700
+27.6%
0.12%
+25.8%
Q4 2016$59,033
-30.5%
523,900
-20.6%
0.09%
-38.0%
Q3 2016$84,891
+24.9%
660,223
+6.2%
0.15%
+16.3%
Q2 2016$67,948
+149.6%
621,723
+116.6%
0.13%
+148.1%
Q1 2016$27,220
+165.2%
287,100
+152.5%
0.05%
+136.4%
Q4 2015$10,265
-69.6%
113,700
-68.7%
0.02%
-72.8%
Q3 2015$33,739
+13.9%
363,723
-19.3%
0.08%
+20.9%
Q2 2015$29,610
+119.7%
450,473
+139.3%
0.07%
+131.0%
Q1 2015$13,476
+451.4%
188,263
+93.6%
0.03%
+383.3%
Q2 2014$2,444
+15.2%
97,223
+22.6%
0.01%
+20.0%
Q4 2013$2,121
-57.3%
79,323
-69.6%
0.01%
-58.3%
Q3 2013$4,966
+74.2%
260,523
+97.0%
0.01%
+71.4%
Q2 2013$2,851132,2230.01%